Avricore Health Inc. AVCRF Archives

TuesdayJan 04, 2022 11:17 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Helping Patients, One Community Pharmacy at a Time

The point-of-care testing market is projected to be valued at $81.37 billion by 2028, representing a CAGR of 9.4% over the forecast period (2020-2028) Avricore plans to capitalize on this growth through investing in its technology and forging strategic partnerships that bring its services closer to patients For the 2021 calendar year, Avricore partnered with Shoppers Drug Mart pharmacy to pilot its HealthTab(TM) platform in specific locations Having capitalized and executed several critical agreements for 2021, the company is confident that it is well-positioned for growth in 2022 Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a pharmacy service innovator, has remained…

WednesdayDec 29, 2021 11:32 am

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Taking Part in POC Testing Revolution with HealthTab(TM)

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is positioning in an era where point-of-care (“POC”) testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more. In the shift to a more decentralized testing approach, Avricore is taking part in this disruption through its POCT platform, HealthTab(TM), found at select community pharmacies. “HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results,” reads a recent article. “The analyzers screen for more than 20 biomarkers associated with select chronic and infectious diseases and communicate them in real-time with patients and…

WednesdayDec 29, 2021 10:56 am

Growth of Point-of-care Lab Testing Means Blue Sky Opportunity for Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) as its Platform Continues to Roll Out

Pharmacy services developer Avricore Health is establishing a network of lab-grade testing and reporting for select medical conditions through neighborhood pharmacy stores Such neighborhood POC store solutions building empowers patients to work with trained pharmacy professionals in monitoring select health conditions, including virus exposure Viruses have become a focal point of health response efforts during the past two years as COVID-19 SARS-CoV-2 infections have claimed millions of lives and sickened scores of others Avricore has thus far established its pilot program in Canada’s eastern Ontario province and western British Columbia province, anticipating strong growth of the HealthTab network in Canada…

WednesdayDec 22, 2021 12:37 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Committed to Creating World’s Largest Rapid Testing Network in Pharmacy

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF), a point-of-care health testing technology innovator, has rolled out its trademarked HealthTab(TM) platform in select Ontario and British Columbia Shoppers Drug Mart network pharmacies. The company continues to add lab-accurate test functionality to its kiosks, most recently announcing a solution for monitoring kidney function. Already, Avricore has agreements with Abbott Laboratories currently in the pilot stage that allow for the testing of markers related to conditions such as diabetes, heart disease and viruses such as SARS-CoV-2, RSV, influenza A and B, and strep, empowering patients who want to take a greater role in managing…

FridayDec 17, 2021 12:10 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Focused on Improving Patient Outcomes, Lowering Overall Health Care Costs

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is celebrating the achievement of key milestones this year, which include an agreement with Abbott Diagnostics to establish in-store kiosks that utilize Avricore’s platform. This builds on an agreement with the Shoppers Drug Mart pharmaceutical chain that makes its platform accessible to patients across Canada. Avricore’s HealthTab(TM) platform is a testing and health data network that draws on data from blood samples and other samples to provide lab-quality results to patients in real-time. “Avricore’s efforts to provide access to the testing solution makes it possible for patients to seek out pharmacies in their local…

ThursdayDec 16, 2021 11:34 am

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Headed into 2022 with Additional Momentum for POC Testing Growth

Point-of-care pharmacy services developer Avricore Health is celebrating the successes of its pilot program to roll out testing resources at select pharmacies across Canada this year Avricore’s trademarked HealthTab platform, working with corporate partners, has provided a popular alternative to doctor clinics for getting test results related to pre-diabetes and heart disease conditions, for example The HealthTab setup, in conjunction with multinational medical devices and health care company Abbott Laboratories, is also able to screen for viruses such as SARS-CoV-2, RSV, influenza A and B, and strep Market analysts predict POC testing revenues will continue to grow through 2025 at…

MondayDec 13, 2021 1:35 pm

Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Participating in the Disruption of Traditional Centralized Laboratory Testing

Point-of-care-testing offers numerous benefits, including faster results, lower costs, improved monitoring and medication adherence, and more It is set to disrupt the clinical chemistry field, promoting a shift to a more decentralized testing approach Avricore is taking part in this disruption through its POCT platform, HealthTab, found at select community pharmacies HealthTab combines point-of-care analyzers that screen for over 20 biomarkers with a consumer-facing interface that displays results Point-of-care testing (“POCT”), experts say, is set to disrupt the clinical chemistry field, with further development in this area facilitating expanded delivery of healthcare to resource-poor environments, providing better tools for monitoring…

FridayDec 10, 2021 10:30 am

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Announces Upcoming Investor Call

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) CEO and other key leaders will be hosting a year-end update call. The call, which will be held on Dec. 15, 2021, at 1 p.m. ET, will also include a discussion about the company’s growth strategy looking forward. According to the company, the one-hour call will include opening remarks, and overview presentation and update, and a Q&A session. Avricore Health is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at moving pharmacy forward. “We’ve had our best year yet, despite many external factors that created headwinds, and we’re extremely excited to head…

ThursdayDec 09, 2021 12:56 pm

QualityStocksNewsBreaks – Avricore Health Inc.’s (TSX.V: AVCR) (OTCQB: AVCRF) Milestones Highlight HealthTab’s Endless Diagnostic Possibilities

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) has, since the company’s inception, been driven by the development of a network of point-of-care (“POC”) analyzers that run on its HealthTab(TM) software in community pharmacies, workplaces and rural areas. Earlier this year, the company signed a deal with Abbott to expand the distribution of its Affinion 2 analyzers in pharmacies. Shortly thereafter, Avricore also entered an agreement with Shoppers Drug Mart to stock HealthTab for diabetes screening in 11 different locations. “The company has recognized an opportunity and capitalizes on established consumer trends, technology advancements, health policy and industry changes to solve a…

FridayDec 03, 2021 1:02 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) on Course to Making Actionable Health Information More Accessible

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is increasing access to the innovations of its walk-in pharmacy diagnostic technology. Recently, the company expanded from key cities in Canada’s eastern locales to sites on the western seaboard, where it hopes to diversify the profile of patients using its service. “The addition of five British Columbia outlets through Avricore’s pilot partnership with nationwide pharmaceutical chain Shoppers Drug Mart is expected to serve as an early booster stage for the company’s plans to serve 600 locations by the end of 2023,” reads a recent article. In an earlier news release, CEO Hector Bremner commented:…

Site Search

Company Search

Tag: Avricore Health Inc. AVCRF